CPIX logo

CPIX Stock Overview

Profile

Full Name:

Cumberland Pharmaceuticals Inc.

Sector:

Healthcare

Country:

United States

IPO:

August 11, 2009

Indexes:

Not included

Description:

Cumberland Pharmaceuticals is a specialty pharmaceutical company focused on developing and marketing innovative medicines. They aim to improve patient care in areas like pain management and critical care, offering products that address unmet medical needs. Their commitment includes research, development, and providing high-quality healthcare solutions.

Events Calendar

Earnings

Next earnings date:

Mar 5, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 5, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 3, 19 B. Riley Securities
Buy
Dec 3, 19 B. Riley
Buy
Nov 18, 19 B. Riley Securities
Buy
Nov 18, 19 B. Riley FBR
Buy
Aug 17, 18 B. Riley Securities
Buy
Aug 17, 18 B. Riley FBR
Buy
May 5, 18 B. Riley FBR
Buy
Apr 17, 18 B. Riley Securities
Buy
Apr 10, 13 UBS
Neutral
Nov 12, 12 UBS
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Cumberland Pharmaceuticals' Duchenne Candidate Shows Improved Heart Function In Patients With Associated Heart Disease
Cumberland Pharmaceuticals' Duchenne Candidate Shows Improved Heart Function In Patients With Associated Heart Disease
Cumberland Pharmaceuticals' Duchenne Candidate Shows Improved Heart Function In Patients With Associated Heart Disease
CPIX
benzinga.comFebruary 4, 2025

On Tuesday, Cumberland Pharmaceuticals Inc.  CPIX released topline results from its Phase 2 FIGHT DMD trial.

Cumberland Pharmaceuticals Announces Breakthrough Results from the Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart Disease
Cumberland Pharmaceuticals Announces Breakthrough Results from the Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart Disease
Cumberland Pharmaceuticals Announces Breakthrough Results from the Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart Disease
CPIX
prnewswire.comFebruary 4, 2025

NASHVILLE, Tenn. , Feb. 4, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company with development efforts focused on new products for rare diseases, today announced positive top-line results from its Phase 2 FIGHT DMD trial.

Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday?
Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday?
Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday?
CPIX
benzinga.comDecember 10, 2024

On Monday, the FDA approved Cumberland Pharmaceuticals Inc's  CPIX supplemental New Drug Application (sNDA) for its Acetadote (N-acetylcysteine for injection) product.

FDA APPROVES ACETADOTE® sNDA
FDA APPROVES ACETADOTE® sNDA
FDA APPROVES ACETADOTE® sNDA
CPIX
prnewswire.comDecember 9, 2024

-  New Dosing Regimen Simplifies Administration  - NASHVILLE, Tenn. , Dec. 9, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on delivering high-quality products to improve patient care, announced today the FDA has approved a supplemental New Drug Application (sNDA) for its Acetadote® (N-acetylcysteine for injection) product.

Cumberland Pharmaceuticals Inc. (CPIX) Q3 2024 Earnings Call Transcript
Cumberland Pharmaceuticals Inc. (CPIX) Q3 2024 Earnings Call Transcript
Cumberland Pharmaceuticals Inc. (CPIX) Q3 2024 Earnings Call Transcript
CPIX
seekingalpha.comNovember 9, 2024

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Molly Aggas - Investor Relations, Dalton Agency A.J. Kazimi - Chief Executive Officer Todd Anthony - Vice President, Organizational Development John Hamm - Chief Financial Officer Conference Call Participants Operator Good afternoon.

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTS
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTS
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTS
CPIX
prnewswire.comOctober 31, 2024

NASHVILLE, Tenn. , Oct. 31, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its third quarter 2024 financial results and provide a company update after the market closes on Thursday, Nov. 7, 2024.

Cumberland Pharmaceuticals Inc. (CPIX) Q2 2024 Earnings Call Transcript
Cumberland Pharmaceuticals Inc. (CPIX) Q2 2024 Earnings Call Transcript
Cumberland Pharmaceuticals Inc. (CPIX) Q2 2024 Earnings Call Transcript
CPIX
seekingalpha.comAugust 11, 2024

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q2 2024 Results Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Molly Aggas - Investor Relations, Dalton Agency A.J. Kazimi - Chief Executive Officer Todd Anthony - Vice President, Organizational Development John Hamm - Chief Financial Officer Conference Call Participants Operator Good afternoon.

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2024 FINANCIAL RESULTS
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2024 FINANCIAL RESULTS
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2024 FINANCIAL RESULTS
CPIX
prnewswire.comJuly 30, 2024

NASHVILLE, Tenn. , July 30, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its second quarter 2024 financial results and provide a company update after the market closes on Tuesday, Aug. 6, 2024.

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS
CPIX
PRNewsWireApril 30, 2024

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, will announce its first quarter 2024 financial results and company update after the market closes on Tuesday, May 7, 2024.

Cumberland Pharmaceuticals Inc. (CPIX) Q4 2023 Earnings Call Transcript
Cumberland Pharmaceuticals Inc. (CPIX) Q4 2023 Earnings Call Transcript
Cumberland Pharmaceuticals Inc. (CPIX) Q4 2023 Earnings Call Transcript
CPIX
Seeking AlphaMarch 5, 2024

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q4 2023 Earnings Conference Call March 5, 2024 4:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A. J. Kazimi - Chairman and Chief Executive Officer Todd Anthony - Vice President, Organizational Development John Hamm - Chief Financial Officer Conference Call Participants Operator Good afternoon, and welcome to Cumberland Pharmaceuticals 2023 Financial Report and Company Update.

  • 1(current)
  • 2
  • 1(current)
  • 2

FAQ

  • What is the ticker symbol for Cumberland Pharmaceuticals?
  • Does Cumberland Pharmaceuticals pay dividends?
  • What sector is Cumberland Pharmaceuticals in?
  • What industry is Cumberland Pharmaceuticals in?
  • What country is Cumberland Pharmaceuticals based in?
  • When did Cumberland Pharmaceuticals go public?
  • Is Cumberland Pharmaceuticals in the S&P 500?
  • Is Cumberland Pharmaceuticals in the NASDAQ 100?
  • Is Cumberland Pharmaceuticals in the Dow Jones?
  • When was Cumberland Pharmaceuticals's last earnings report?
  • When does Cumberland Pharmaceuticals report earnings?
  • Should I buy Cumberland Pharmaceuticals stock now?

What is the ticker symbol for Cumberland Pharmaceuticals?

The ticker symbol for Cumberland Pharmaceuticals is NASDAQ:CPIX

Does Cumberland Pharmaceuticals pay dividends?

No, Cumberland Pharmaceuticals does not pay dividends

What sector is Cumberland Pharmaceuticals in?

Cumberland Pharmaceuticals is in the Healthcare sector

What industry is Cumberland Pharmaceuticals in?

Cumberland Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is Cumberland Pharmaceuticals based in?

Cumberland Pharmaceuticals is headquartered in United States

When did Cumberland Pharmaceuticals go public?

Cumberland Pharmaceuticals's initial public offering (IPO) was on August 11, 2009

Is Cumberland Pharmaceuticals in the S&P 500?

No, Cumberland Pharmaceuticals is not included in the S&P 500 index

Is Cumberland Pharmaceuticals in the NASDAQ 100?

No, Cumberland Pharmaceuticals is not included in the NASDAQ 100 index

Is Cumberland Pharmaceuticals in the Dow Jones?

No, Cumberland Pharmaceuticals is not included in the Dow Jones index

When was Cumberland Pharmaceuticals's last earnings report?

Cumberland Pharmaceuticals's most recent earnings report was on Nov 7, 2024

When does Cumberland Pharmaceuticals report earnings?

The next expected earnings date for Cumberland Pharmaceuticals is Mar 5, 2025

Should I buy Cumberland Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions